ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,797.60
      -0.51%
      US Tech 100
      20,065.60
      -1.09%
      Dow Jones
      42,121.26
      0.44%
      Brent Oil
      80.375
      -0.30%
      Bitcoin
      92,342.00
      -2.27%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Eupraxia Pharmaceuticals Inc (EPRX) Quote

      Eupraxia Pharmaceuticals Inc

      Eupraxia Pharmaceuticals Inc (EPRX)

      Eupraxia Pharmaceuticals Inc
      3.00
      0.00
      ( 0.00% )
      Updated: 09:46:35
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      3.00
      Bid
      3.00
      Ask
      3.05
      Volume
      817
      3.00 Day's Range 3.05
      2.20 52 Week Range 4.08
      Market Cap
      106.868M
      Previous Close
      3.00
      Open
      3.05
      Last Trade
      40
      @
      3
      Last Trade Time
      10:18:19
      Financial Volume
      $ 2,456
      VWAP
      3.0057
      Average Volume (3m)
      16,981
      Shares Outstanding
      35,622,553
      Dividend Yield
      -
      PE Ratio
      -5.45
      Earnings Per Share (EPS)
      -0.79
      Revenue
      -
      Net Profit
      -28.22M

      About Eupraxia Pharmaceuticals Inc

      Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient be... Eupraxia Pharmaceuticals Inc is a clinical-stage biotechnology company focused on the development of locally delivered, extended-release alternatives to existing pharmaceuticals. Its product candidates address therapeutic areas with a high unmet medical need and strive to provide improved patient benefit by delivering targeted, long-lasting activity with fewer side effects. Its lead product candidate, EP-104IAR, is in development for the treatment of pain due to osteoarthritis of the knee. In addition, it is developing a pipeline of earlier-stage long-acting formulations. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.eupraxiapharma.com
      Headquarters
      Victoria, British Columbia, Can
      Founded
      -
      Eupraxia Pharmaceuticals Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker EPRX. The last closing price for Eupraxia Pharmaceuticals was $3. Over the last year, Eupraxia Pharmaceuticals shares have traded in a share price range of $ 2.20 to $ 4.08.

      Eupraxia Pharmaceuticals currently has 35,622,553 shares outstanding. The market capitalization of Eupraxia Pharmaceuticals is $106.87 million. Eupraxia Pharmaceuticals has a price to earnings ratio (PE ratio) of -5.45.

      Ask ADVFN Intelligence (AI)

      EPRX Latest News

      More News

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 20 2024
      Edgar (US Regulatory)

      Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months

      Eupraxia's DiffuSphere™ Technology Demonstrates Targeted Drug Release while Minimizing Systemic Exposure for a Period of More Than Six Months PR Newswire VICTORIA, BC, Nov. 20, 2024...

      November 20 2024
      PR Newswire (US)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 14 2024
      Edgar (US Regulatory)

      Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting

      Eupraxia Pharmaceuticals to Present at American College of Rheumatology Convergence 2024 Annual Meeting PR Newswire VICTORIA, BC, Nov. 14, 2024 VICTORIA, BC, Nov. 14, 2024 /PRNewswire/ - Eupraxia...

      November 14 2024
      PR Newswire (US)

      Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]

      November 13 2024
      Edgar (US Regulatory)

      Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024

      Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November...

      November 13 2024
      PR Newswire (Canada)

      Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis

      Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis Canada NewsWire VICTORIA, BC, Nov. 12, 2024...

      November 12 2024
      PR Newswire (Canada)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.12-3.846153846153.123.122.9519373.01924504CS
      4-0.45-13.04347826093.453.52.7563133.15285139CS
      120.4919.52191235062.514.082.31169813.26669745CS
      260.134.529616724742.874.082.2116553.03982435CS
      52-0.55-15.49295774653.554.082.2154012.93707231CS
      156-0.55-15.49295774653.554.082.2154012.93707231CS
      260-0.55-15.49295774653.554.082.2154012.93707231CS

      EPRX - Frequently Asked Questions (FAQ)

      What is the current Eupraxia Pharmaceuticals share price?
      The current share price of Eupraxia Pharmaceuticals is $ 3.00
      How many Eupraxia Pharmaceuticals shares are in issue?
      Eupraxia Pharmaceuticals has 35,622,553 shares in issue
      What is the market cap of Eupraxia Pharmaceuticals?
      The market capitalisation of Eupraxia Pharmaceuticals is USD 106.87M
      What is the 1 year trading range for Eupraxia Pharmaceuticals share price?
      Eupraxia Pharmaceuticals has traded in the range of $ 2.20 to $ 4.08 during the past year
      What is the PE ratio of Eupraxia Pharmaceuticals?
      The price to earnings ratio of Eupraxia Pharmaceuticals is -5.45
      What is the reporting currency for Eupraxia Pharmaceuticals?
      Eupraxia Pharmaceuticals reports financial results in USD
      What is the latest annual profit for Eupraxia Pharmaceuticals?
      The latest annual profit of Eupraxia Pharmaceuticals is USD -28.22M
      What is the registered address of Eupraxia Pharmaceuticals?
      The registered address for Eupraxia Pharmaceuticals is 201 - 2067 CADBORO BAY ROAD, VICTORIA, BRITISH COLUMBIA, V8R 5G4.
      What is the Eupraxia Pharmaceuticals website address?
      The website address for Eupraxia Pharmaceuticals is www.eupraxiapharma.com
      Which industry sector does Eupraxia Pharmaceuticals operate in?
      Eupraxia Pharmaceuticals operates in the PHARMACEUTICAL PREPARATIONS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      PHIOPhio Pharmaceuticals Corporation
      $ 8.35
      (394.08%)
      		131.7M
      SLRXSalarius Pharmaceuticals Inc
      $ 4.07
      (160.06%)
      		54.52M
      ATPCAgape ATP Corporation
      $ 2.059
      (63.41%)
      		54.12M
      LITMSnow Lake Resources Ltd
      $ 0.9774
      (43.97%)
      		43.21M
      SAGESage Therapeutics Inc
      $ 7.4612
      (34.44%)
      		4.42M
      SVMHSRIVARU Holding Ltd
      $ 0.04105
      (-33.58%)
      		85.69M
      CMTLComtech Telecommunications Corporation
      $ 2.8001
      (-32.20%)
      		1.11M
      NAYANAYA Biosciences Inc
      $ 0.5534
      (-31.96%)
      		540.28k
      SMXSMX Security Matters Public Company
      $ 0.2746
      (-31.56%)
      		8.92M
      TCTMTCTM Kids IT Education Inc
      $ 0.52
      (-29.21%)
      		379.72k
      GCTKGlucoTrack Inc
      $ 0.13565
      (15.94%)
      		491.28M
      PHIOPhio Pharmaceuticals Corporation
      $ 8.35
      (394.08%)
      		131.7M
      BHATBlue Hat Interactive Entertainment Technology
      $ 0.0628
      (-28.72%)
      		95.45M
      SVMHSRIVARU Holding Ltd
      $ 0.04105
      (-33.58%)
      		85.69M
      NVDANVIDIA Corporation
      $ 131.541
      (-3.21%)
      		69.82M

      Discussion

      View Full Feed
      money6870 money6870 6 seconds ago
      When I messeged Tony acouple months ago, I said asked if there were no takers and if the OS reduction was off, he claimed he had takers and it was going to happen. But unfortunately it seems Tony says things and it don't happen.
      APRU
      mikeymac mikeymac 9 seconds ago
      I used to chop wood, but we could tell where we were in the chopping. Is anything getting close to coming down, or coming apart. It looks like a lot of time between the chopping, and something getting to the bank, or someone's pockets. Feel free to put anyones
      BOPO
      glenn1919 glenn1919 18 seconds ago
      atpc.......stim.......gctk.........elev.......https://stockcharts.com/h-sc/ui?s=stim&p=D&yr=0&mn=2&dy=12&id=p84071410134
      ladykiller50 ladykiller50 24 seconds ago
      WRONG!!!!!!!!!!!!!!!!!!!!!!!!!
      VXIT
      willpellel willpellel 48 seconds ago
      One question for the "Top Basher"............

      Why are you still around?

      You made your point, PSRU is a SCAM and Xavier is a WANNABE and the rest of us are Jack Asses

      So WHY?
      PSRU
      north40000 north40000 57 seconds ago
      JNJ buys ITCI for ~ 4.8 Billion.
      JNJ
      DL11 DL11 57 seconds ago
      Closing in on 50 day MA, let's see if we get a bounce or if the overall market is so weak that just about everything continues down. If everything continues down, companies with no earnings and negative cash flow such as SOUN will experience disproportionate downward movement, IMO.
      SOUN
      halbroke1 halbroke1 1 minute ago
      UMAV $$$ ABOUT TO GET MONSTER STATUS!!! FROM .04+ TO .40+ TO $4.00+..
      UMAV
      RIGATONI RIGATONI 1 minute ago
      $4.81 News...

      https://www.globenewswire.com/news-release/2025/01/13/3008681/0/en/ASP-Isotopes-Inc-Hosts-Investor-Access-Event-in-South-Africa-Providing-Updates-on-its-Silicon-28-Ytterbium-176-and-Carbon-14-Facilities.html
      getmoreshares getmoreshares 1 minute ago
      .1257
      BLRX
      2cents4one 2cents4one 1 minute ago
      The proportion of buying to selling is increasing again. For a while it was trying to equal out. I think the .04 sellers are almost, if not gone.
      I don't think we will see much of a dip until it gets to higher levels.
      UMAV
      gdog gdog 2 minutes ago
      well its one thing to be disappointed and a whole nother to make up false statements...
      NLST
      budfoxfun budfoxfun 2 minutes ago
      SGTM is capitalizing on the expertise and knowledge of Chad Roy, Bobby Mann of Mann Marketing, and Gus Ibrahim of Worldwide TV Products, who have agreed to join the SGTM team as strategic advisors. Their invaluable contributions will accelerate the growth of SGTM's "Direct to Retail" operations, ens
      SGTM
      CaptBeer CaptBeer 2 minutes ago
      https://www.linkedin.com/feed/update/urn:li:activity:7284515765330845697?commentUrn=urn%3Ali%3Acomment%3A%28activity%3A7284515765330845697%2C7284593113216557056%29&dashCommentUrn=urn%3Ali%3Afsd_comment%3A%287284593113216557056%2Curn%3Ali%3Aactivity%3A7284515765330845697%29
      AMRN
      AJH92 AJH92 2 minutes ago
      News - January 13. Valiant Eagle’s [OTC PSRU] VE Gaming Secures Landmark Distribution Agreement with Nexgen Games Ltd

      https://www.otcmarkets.com/stock/PSRU/news/Valiant-Eagles-OTCPSRU-VE-Gaming-Secures-Landmark-Distribution-Agreement-with-Nexgen-Games-Ltd?id=464338
      PSRU
      AveragePenny AveragePenny 2 minutes ago
      $BULT - " - Global Bitcoin ATMs growing fast! We are built for success!

      #crypto #cryptocurrency #btc #ethereum #investing #money #forex #investment #bult #bultstock #bitcoin #blockchain #bitcoinatm
      "

      https://x.com/BULT_stock/status/1878816482081312984
      BULT
      BottomBounce BottomBounce 3 minutes ago
      Electric Vehicle Maker $ALYI MIA Global, Inc. to acquire controlling interest in Alternet Systems, Inc. For more information, please visit: www.mia-global.com and http://www.alternetbike.com.
      ALYI
      glenn1919 glenn1919 3 minutes ago
      vrme......nrxp.....uvix......tpet......slrx...................https://stockcharts.com/h-sc/ui?s=slrx&p=D&yr=0&mn=2&dy=12&id=p84071410134..........
      nidan7500 nidan7500 3 minutes ago
      Why the sp going down? Should be opposite.
      AVXL
      BottomBounce BottomBounce 3 minutes ago
      Electric Vehicle Maker $ALYI MIA Global, Inc. to acquire controlling interest in Alternet Systems, Inc. For more information, please visit: www.mia-global.com and http://www.alternetbike.com.
      ALYI
      B RY B RY 3 minutes ago
      News not on ihubub yet. "These positive results in the early stages of dose escalation offer promise for our vision, 'striving for a cancer free future' using INTASYL technology" said Robert Bitterman, CEO of Phio Pharmaceuticals."
      https://www.newsfilecorp.com/release/236693/Phio-Pharmaceutic
      PHIO
      100lbStriper 100lbStriper 3 minutes ago
      lol!!!
      NLST
      tzebedee tzebedee 3 minutes ago
      You’re joking, right?
      FNMA
      OPKOHEALTH2022 OPKOHEALTH2022 4 minutes ago
      Maybe he is and maybe he is not a promoter. Most likely he is a promoter getting paid to persuade others. And I tell you if he is a promoter then he is worse than a thief or maybe equal because he is lying .
      FCEL
      Jakilla11 Jakilla11 4 minutes ago
      how do I get this absolute hunk of complete junk scam POS company out of my e-trade portfolio? It just sits there with a 100% loss and I want to get rid of it since it reminds me every time I log in what a complete waste of money this was. It wont let me sell it.

      Your Recent History

      NASDAQ
      EPRX
      Eupraxia Pharmaceuticals
      BIT
      S24548
      SG ISSUER
      BIT
      P22462
      NLBNPIT22462 20991231 41...
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads